PTSD Trial, Recruiting NCT05701111 Sponsor: Stanford University Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT05701111
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Teachers, students, adults, and caregivers at a participating school who are willing to take part in the study
  • Young people aged 11 to 17 who have experienced at least one traumatic event and are showing significant trauma-related symptoms (as measured by a standard UCLA questionnaire)
  • Young people who are willing to take part in therapy sessions
  • A caregiver of the young person who is also willing to take part in therapy sessions
  • The person who caused the traumatic event must not be currently living in the same home as the young person

Who may not be able to join:

  • Students who are already receiving trauma-focused therapy from a mental health professional
  • Young people with significantly lower than average cognitive (thinking and learning) abilities, specifically an IQ below 70
  • People with a serious dependency on drugs or alcohol (as defined by standard medical guidelines)
  • People who have been diagnosed with autism or schizophrenia
  • People with a serious ongoing physical health condition (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Victor Carrion, M.D., John A. Turner, M.D. Professor and Vice-Chair of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Early Life Stress and Resilience Program

Phone: (650) 721-3582

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 February 2024
Est. completion
1 May 2027

Where this trial is recruiting

Puerto Rico 🇺🇸 United States

Primary endpoints

Mean Change from Baseline in Resilience Score; Mean Change from Baseline in Work Self-Efficacy Score; Mean Change from Baseline in Anxiety Score; Mean Change from Baseline in Depression Score; Mean Change from Baseline in Somatic Symptoms Score; Changes in Methylation Pattern of Genes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov